BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA Peptide Reclassification 2026: What It Means for Providers Orthopedic Use of BPC 157 Sports Med Review FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Is BPC157 Legal? WADA, FDA Status, and What You Need to Know Everything You Need to Know About the FDA Peptide Ban